University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

Healthy Bones Study

Not Applicable

Completed

Conditions: Locally Advanced Malignant Neoplasm

Interventions: Behavioral: Bone health educational materials

First Posted Date: 2013-10-31

Last Posted Date: 2017-05-08

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 200

Registration Number: NCT01973673

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

EBUS/Spectrum Analysis

Completed

Conditions: Lung Cancer

Interventions: Device: Spectrum Image Analysis using a Linear Array Ultrasound Bronchoscope

First Posted Date: 2013-10-30

Last Posted Date: 2018-02-23

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 122

Registration Number: NCT01972386

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Novel Technique of Analgesia Following Open Liver Resection

Phase 4

Completed

Conditions: Postoperative Pain
Liver Resection

Interventions: Procedure: saline and IV PCA
Procedure: ropivacaine + iv PCA

First Posted Date: 2013-10-10

Last Posted Date: 2017-08-01

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 150

Registration Number: NCT01960049

Locations: 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada
🇨🇦
Sunnybrook Health Science Centre, Toronto, Ontario, Canada

Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon Like Peptide 2

Phase 3

Completed

Conditions: Dyslipidemia

Interventions: Drug: Placebo
Drug: GLP-2

First Posted Date: 2013-10-09

Last Posted Date: 2015-03-10

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 12

Registration Number: NCT01958775

Locations: 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada

A Study of CFI-400945 Fumarate in Patients With Advanced Cancer

Phase 1

Completed

Conditions: Advanced Cancer

Interventions: Drug: CFI-400945

First Posted Date: 2013-10-01

Last Posted Date: 2024-01-17

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 46

Registration Number: NCT01954316

Locations: 🇺🇸
UCLA Medical Center, Santa Monica, California, United States
🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Study Using Combined Virtual 4-D Electromagnetic (EM) Tip-Tracked Devices & EBUS in Diagnosis of Lung Nodules

Not Applicable

Completed

Conditions: Lung Cancer

Interventions: Procedure: Navigational Bronchoscopy
Procedure: Standard Bronchoscopy

First Posted Date: 2013-09-20

Last Posted Date: 2020-03-25

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 11

Registration Number: NCT01947530

Locations: 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada

Exenatide for Myocardial Protection During Reperfusion Study

Phase 2

Conditions: Myocardial Infarction

Interventions: Drug: Placebo
Drug: Exenatide

First Posted Date: 2013-09-10

Last Posted Date: 2016-08-05

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 198

Registration Number: NCT01938235

Locations: 🇨🇦
Institut universitaire de cardiologie et de pneumologie de Quebec (Hopital Laval), Quebec City, Quebec, Canada
🇨🇦
Toronto General Hospital, University Health Network, Toronto, Ontario, Canada
🇨🇦
Southlake Regional Health Centre, Newmarket, Ontario, Canada

and more 7 locations

Famotidine for Levodopa-induced Dyskinesia in PD

Phase 2

Completed

Conditions: Dyskinesia

Interventions: Drug: Famotidine

First Posted Date: 2013-09-09

Last Posted Date: 2014-05-05

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 7

Registration Number: NCT01937078

Locations: 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

Benefits of Exercise in Alzheimer's Disease

Not Applicable

Conditions: Alzheimer's Disease

Interventions: Other: Personalized Exercise Regimen

First Posted Date: 2013-09-04

Last Posted Date: 2019-09-25

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 60

Registration Number: NCT01935024

Locations: 🇨🇦
Toronto Western Hospital, WW5-449, Toronto, Ontario, Canada

Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-Leukemia

Phase 1

Completed

Conditions: Chronic Phase Chronic Myeloid Leukemia
Accelerated Phase Chronic Myeloid Leukemia
Blastic Phase Chronic Myeloid Leukemia
Resistant to Tyrosine Kinase Inhibitor Therapy
Philadelphia Positive Acute Lymphoblastic Leukemia

Interventions: Drug: Nilotinib
Drug: Ruxolitinib

First Posted Date: 2013-08-02

Last Posted Date: 2020-11-02

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 4

Registration Number: NCT01914484

Locations: 🇨🇦
Princess Margaret Hospital / University Health Network, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy